SC 13G/A | 2008-02-13 | STEPHENS PAUL BARTLETT | BIOCRYST PHARMACEUTICALS INC | 3,411,001 | 9.0% | EDGAR |
SC 13G/A | 2008-02-13 | STEPHENS WILLIAM BRADFORD | BIOCRYST PHARMACEUTICALS INC | 3,411,001 | 9.0% | EDGAR |
SC 13D/A | 2007-08-20 | DOERR L JOHN | BIOCRYST PHARMACEUTICALS INC | 371,472 | 0.1% | EDGAR |
SC 13D/A | 2007-08-08 | BAKER JULIAN | BIOCRYST PHARMACEUTICALS INC | 7,501,744 | 19.1% | EDGAR |
SC 13G | 2007-02-13 | Stephens Investment Management, LLC | BIOCRYST PHARMACEUTICALS INC | - | 5.3% | EDGAR |
SC 13G | 2007-02-13 | STEPHENS PAUL BARTLETT | BIOCRYST PHARMACEUTICALS INC | - | 5.3% | EDGAR |
SC 13G | 2007-02-13 | STEPHENS PAUL HARBOUR | BIOCRYST PHARMACEUTICALS INC | - | 5.3% | EDGAR |
SC 13G | 2007-02-13 | STEPHENS WILLIAM BRADFORD | BIOCRYST PHARMACEUTICALS INC | - | 5.3% | EDGAR |
SC 13D/A | 2006-03-16 | BAKER JULIAN | BIOCRYST PHARMACEUTICALS INC | 1,774,838 | 6.1% | EDGAR |
SC 13G/A | 2006-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | BIOCRYST PHARMACEUTICALS INC | 1,015,100 | 3.5% | EDGAR |
SC 13G/A | 2006-02-14 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2006-02-14 | EDELMAN JOSEPH | BIOCRYST PHARMACEUTICALS INC | 608,300 | 2.1% | EDGAR |
SC 13D | 2005-12-23 | DOERR L JOHN | BIOCRYST PHARMACEUTICALS INC | 1,485,886 | 5.2% | EDGAR |
SC 13D/A | 2005-12-07 | ORBIMED ADVISORS LLC | BIOCRYST PHARMACEUTICALS INC | 91,000 | 0.3% | EDGAR |
SC 13D/A | 2005-12-07 | ORBIMED CAPITAL II LLC | BIOCRYST PHARMACEUTICALS INC | 91,000 | 0.3% | EDGAR |
SC 13D/A | 2005-12-07 | ISALY SAMUEL D | BIOCRYST PHARMACEUTICALS INC | 91,000 | 0.3% | EDGAR |
SC 13G | 2005-10-25 | EDELMAN JOSEPH | BIOCRYST PHARMACEUTICALS INC | 1,651,828 | 6.3% | EDGAR |
SC 13D | 2005-10-13 | BAKER JULIAN | BIOCRYST PHARMACEUTICALS INC | 2,344,036 | 9.0% | EDGAR |
SC 13G | 2005-02-25 | BAKER FELIX | BIOCRYST PHARMACEUTICALS INC | 1,597,603 | 6.1% | EDGAR |
SC 13G | 2005-02-25 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 2,051,500 | 7.9% | EDGAR |